ClinicalTrials.govpublic full text
A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.
carcinoma, renal cell, glioblastoma, carcinoma, hepatocellular, phase 1b, crizotinib, sunitinib, axitinib, sorafenib, bevacizumab, cmet inhibitor, vegf inhibitor, crizotinib combination
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 915907
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.